Simulus™ 800SR36Recalls & reported problems
Medtronic, Inc. · RING SIM SR 800SR36 SEMI-RIGID · Class 2 · Implant
- Adverse event reports
- 19
- Deaths reported
- 0
- Injuries reported
- 19
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 19 adverse event reports that list this exact device (DI 00643169182257), received between Oct 12, 2017 and Mar 24, 2025 — classified as 19 injuries.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (14 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Insufficient Device Problem Information14
- Adverse Event Without Identified Device or Use Problem3
- Inadequacy of Device Shape and/or Size2
- Intravalvular regurgitation2
- Material Separation1
- Patient Device Interaction Problem1
Patient problems
- Insufficient Information8
- Mitral Valve Insufficiency/ Regurgitation6
- Mitral Regurgitation4
- No Information4
- Pericardial Effusion1
- Pleural Effusion1
Recent adverse event reports
The 19 most recent of 19 reports, in the reporter's own words as published by the FDA.
InjuryMar 24, 2025Intravalvular regurgitation; Intravalvular regurgitation
MEDTRONIC RECEIVED INFORMATION THAT 5 YEARS AND 6 MONTHS POST IMPLANT OF THIS 36MM MITRAL ANNULOPLASTY RING, IT WAS REPORTED THAT A TRANSESOPHAGEAL ECHOCARDIOGRAM (TEE) DISCOVERED SEVERE MITRAL REGURGITATION. NO INTERVENTION IS SCHEDULED. NO ADDITIONAL ADVERSE PA TIENT EFFECTS WERE REPORTED.
Patient problems: Mitral Valve Insufficiency/ Regurgitation
MAUDE report 21678410 ↗InjuryMar 24, 2025Insufficient Device Problem Information; Intravalvular regurgitation; Insufficient Device Problem Information; Intravalvular regurgitation
ADDITIONAL INFORMATION WAS RECEIVED THAT REPORTED THE REASON FOR REPLACEMENT AS MITRAL INSUFFICIENCY. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information; Mitral Valve Insufficiency/ Regurgitation
MAUDE report 21677820 ↗InjuryMar 1, 2024Patient Device Interaction Problem; Patient Device Interaction Problem
MEDTRONIC RECEIVED INFORMATION THAT 1 WEEK POST IMPLANT OF THIS 36MM MITRAL ANNULOPLASTY RING, PLEURAL EFFUSION WAS REPORTED. A "PLEURAL PUNCTION" WAS PERFORMED TO REMOVE EXCESS FLUID FROM THE SPACE BETWEEN THE LUNGS AND THE CHEST WALL. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Pleural Effusion
MAUDE report 18818010 ↗InjuryFeb 20, 2024Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 2 YEARS AND 2 MONTHS POST IMPLANT OF THIS 36MM MITRAL ANNULOPLASTY RING, IT WAS EXPLANTED AND REPLACED WITH A 31MM ANNULOPLASTY BAND OF A DIFFERENT MODEL. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 18739492 ↗InjuryAug 25, 2023Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 8 YEARS AND 7 MONTHS POST IMPLANT OF THIS 36MM MITRAL ANNULOPLASTY RING, IT WAS EXPLANTED AND REPLACED WITH AN ANNULOPLASTY BAND OF THE SAME SIZE. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 17622765 ↗InjuryAug 22, 2023Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 4 YEARS AND 1 MONTH POST IMPLANT OF THIS 36MM MITRAL ANNULOPLASTY RING, IT WAS EXPLANTED AND REPLACED WITH A 29MM MITRAL BIOPROSTHETIC VALVE. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 17594897 ↗InjuryJun 21, 2023Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT APPROXIMATELY 1 YEAR POST IMPLANT OF THIS 36MM MITRAL ANNULOPLASTY RING, IT WAS REPORTED THAT A TRANSTHORACIC ECHOCARDIOGRAM (TTE) SHOWED THE PRESENCE OF GRADE III RECURRENT MITRAL REGURGITATION. IT WAS STATED THAT IT IS POSSIBLY RELATED TO THE DEVICE. NO INTERVENTION OR ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Mitral Valve Insufficiency/ Regurgitation
MAUDE report 17170790 ↗InjuryApr 14, 2023Material Separation; Insufficient Device Problem Information; Material Separation; Insufficient Device Problem Information
MEDTRONIC RECEIVED ADDITIONAL INFORMATION WHICH STATED THAT THE REASON FOR THE REPLACEMENT WAS SEVERE MITRAL REGURGITATION AND RING DEHISCENCE FROM THE POSTEROMEDIAL TRIGONE LATERAL TO THE A3 SCALLOP AND A FLAIL P2 LEAFLET WITH ALL ITS CHORDAE RUPTURED. IT WAS NOTED THAT THE RING APPEARED DEFORMED IN SHAPE AND IT WAS THOUGHT THAT THE POSTERIOR ANNULUS HAD DILATED OUT. IT WAS ALSO NOTED THAT A TRIVIAL PERICARDIAL EFFUSION HAD BEEN OBSERVED ON TRANSESOPHAGEAL ECHOCARDIOGRAM PRIOR TO THE REPLACEMENT PROCEDURE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information; Mitral Valve Insufficiency/ Regurgitation; Pericardial Effusion
MAUDE report 16743034 ↗InjuryMar 15, 2023Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 2 YEARS AND 5 MONTHS POST IMPLANT OF THIS 36MM MITRAL ANNULOPLASTY RING, IT WAS EXPLANTED AND REPLACED WITH A 29MM MITRAL BIOPROSTHETIC VALVE. THE REASON FOR THE REPLACEMENT WAS REPORTED AS RECURRENT MITRAL REGURGITATION. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Mitral Valve Insufficiency/ Regurgitation
MAUDE report 16545386 ↗InjuryNov 14, 2022Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 36MM MITRAL ANNULOPLASTY RING, IT WAS EXPLANTED AND REPLACED WITH A 31MM MITRAL BIOPROSTHETIC VALVE. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 15788935 ↗InjuryApr 19, 2022Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 36MM MITRAL ANNULOPLASTY RING, IT WAS EXPLANTED AND REPLACED WITH A 31MM MITRAL BIOPROSTHETIC VALVE. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 14140321 ↗InjuryApr 13, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 36MM MITRAL ANNULOPLASTY RING, IT WAS EXPLANTED AND REPLACED WITH A 29MM BIOPROSTHETIC VALVE. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information; Mitral Valve Insufficiency/ Regurgitation
MAUDE report 14104447 ↗InjuryJul 7, 2020Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 36MM MITRAL ANNULOPLASTY RING, IT WAS EXPLANTED AND REPLACED WITH A 36MM TRICUSPID BAND IMPLANTED IN THE MITRAL POSITION. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Information
MAUDE report 10239791 ↗InjuryJun 2, 2020Inadequacy of Device Shape and/or Size; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Inadequacy of Device Shape and/or Size; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT A 36MM ANNULOPLASTY MITRAL BAND WAS IMPLANTED AND EXPLANTED ON THE SAME DAY. IT WAS REPORTED THAT THE 36MM ANNULOPLASTY BAND WAS REPLACED BY A BIOPROSTHETIC HEART VALVE. THE REASON FOR REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Information
MAUDE report 10112898 ↗InjuryMar 5, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
MEDTRONIC RECEIVED INFORMATION THAT IMMEDIATELY POST IMPLANT OF THIS 36MM MITRAL ANNULOPLASTY RING, IT WAS EXPLANTED AND REPLACED WITH A NON-MEDTRONIC BIOPROSTHETIC VALVE. THE REASON FOR REPLACEMENT WAS REPORTED AS RESIDUAL MITRAL REGURGITATION. THE PHYSICIAN REPORTED THAT THERE WERE NO ISSUES WITH THE ANNULOPLASTY RING ITSELF. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Mitral Regurgitation
MAUDE report 9793027 ↗InjuryApr 18, 2018Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS MITRAL ANNULOPLASTY RING, THE RING WAS IMPLANTED AND EXPLANTED. THE REASON FOR EXPLANT WAS REPORTED WAS RECURRENT REGURGITATION AFTER THE BAND WAS IN PLACE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Mitral Regurgitation
MAUDE report 7439961 ↗InjuryDec 14, 2017Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT IMMEDIATELY POST IMPLANT OF THIS 36MM ANNULOPLASTY RING, THE RING WAS EXPLANTED AND REPLACED WITH A 31MM NON-MEDTRONIC VALVE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Information
MAUDE report 7116710 ↗InjuryDec 12, 2017Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT THIS 36 MM MITRAL ANNULOPLASTY BAND WAS IMPLANTED AND EXPLANTED AND REPLACED WITH A 27 MM MITRAL BIOPROSTHETIC VALVE DURING THE SAME PROCEDURE FOR UNKNOWN REASONS. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Mitral Regurgitation; No Information
MAUDE report 7108159 ↗InjuryOct 12, 2017Inadequacy of Device Shape and/or Size; Inadequacy of Device Shape and/or Size
MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 36MM ANNULOPLASTY RING, THE PHYSICIAN NOTED THAT THERE WAS CONTINUED MITRAL REGURGITATION FROM THE PATIENTS NATIVE TISSUE. THE PHYSICIAN THEN EXPLANTED THE 36MM RING AND REPLACED IT WITH A 31MM BIOPROSTHETIC MITRAL VALVE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Mitral Regurgitation
MAUDE report 6946276 ↗
Other RING, ANNULOPLASTY devices
- CG FUTURE™ 638BL32Medtronic, Inc. · RING, ANNULOPLASTY1 death71 reports
- PROFILE 3D® 680R28Medtronic, Inc. · RING, ANNULOPLASTY1 death67 reports
- CG FUTURE™ 638BL30Medtronic, Inc. · RING, ANNULOPLASTY1 death65 reports
- CG FUTURE™ 638RL32Medtronic, Inc. · RING, ANNULOPLASTY59 reports
- Tri-Ad™ 900SFC228Medtronic, Inc. · RING, ANNULOPLASTY4 deaths56 reports
- CG FUTURE™ 638BL34Medtronic, Inc. · RING, ANNULOPLASTY51 reports
- Contour 3D® 690R30Medtronic, Inc. · RING, ANNULOPLASTY1 death50 reports
- CG FUTURE™ 638RL30Medtronic, Inc. · RING, ANNULOPLASTY1 death47 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.